INGELHEIM, Germany & SINGAPORE--(BUSINESS WIRE)--Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 ...

Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based on ...

(A) Schematic illustration of the synthesis process for a carbon material with controlled mesoscale porosity. (B) External view of the 1-Wh-class stacked lithium-air battery fabricated in this study.

BASEL, Switzerland--(BUSINESS WIRE)--Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, ...

New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing the systemic tolerability profile Head-to-head ...

Jeito Capital (“Jeito”), a leading global independent private equity fund dedicated to Biopharma, is leading an oversubscribed $75 million (€ 65 million 2 ) Series C financing round in Adcendo ApS ...

China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Allergic Rhinitis ...